loadpatents
name:-0.03571891784668
name:-0.016849994659424
name:-0.011162996292114
Herr; Robert Jason Patent Filings

Herr; Robert Jason

Patent Applications and Registrations

Patent applications and USPTO patent grants for Herr; Robert Jason.The latest application filed is for "5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same".

Company Profile
10.19.24
  • Herr; Robert Jason - Voorheesville NY
  • Herr; Robert Jason - Chesterbrook PA
  • Herr; Robert Jason - King of Prussia PA
  • Herr; Robert Jason - Voortheesville NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
Grant 11,414,425 - Mekonnen , et al. August 16, 2
2022-08-16
7-membered aza-heterocyclic containing .delta.-opioid receptor modulating compounds, methods of using and making the same
Grant 11,225,487 - Speerschneider , et al. January 18, 2
2022-01-18
Potent gamma-secretase modulators
Grant 11,117,884 - Wagner , et al. September 14, 2
2021-09-14
5-membered Aza-heterocyclic Containing Delta-opioid Receptor Modulating Compounds, Methods Of Using And Making The Same
App 20210061790 - SPEERSCHNEIDER; Aimee CROMBIE ;   et al.
2021-03-04
7-membered Aza-heterocyclic Containing Delta-opioid Receptor Modulating Compounds, Methods Of Using And Making The Same
App 20210061812 - SPEERSCHNEIDER; Aimee CROMBIE ;   et al.
2021-03-04
Neuroactive Steroids, Compositions, And Uses Thereof
App 20210061848 - Martinez Botella; Gabriel ;   et al.
2021-03-04
6-membered Aza-heterocyclic Containing Delta-opioid Receptor Modulating Compounds, Methods Of Using And Making The Same
App 20200231564 - Speerschneider; Aimee Crombie ;   et al.
2020-07-23
Methods and intermediates for the preparation of omacetaxine and cephalotaxine derivatives thereof
Grant 10,597,401 - Herr , et al.
2020-03-24
Potent Gamma-secretase Modulators
App 20200055840 - Wagner; Steven L. ;   et al.
2020-02-20
Benzodiazepine Derivatives, Compositions, And Methods For Treating Cognitive Impairment
App 20200048268 - Mekonnen; Belew ;   et al.
2020-02-13
Potent gamma-secretase modulators
Grant 10,472,346 - Wagner , et al. Nov
2019-11-12
6-membered Aza-heterocyclic Containing Delta-opioid Receptor Modulating Compounds, Methods Of Using And Making The Same
App 20190202803 - Speerschneider; Aimee Crombie ;   et al.
2019-07-04
6-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
Grant 10,246,436 - Speerschneider , et al.
2019-04-02
Methods And Intermediates For The Preparation Of Omacetaxine And Cephalotaxine Derivatives Thereof
App 20180134724 - HERR; Robert Jason ;   et al.
2018-05-17
Potent Gamma-secretase Modulators
App 20180093967 - Wagner; Steven L. ;   et al.
2018-04-05
Substituted prolines/piperidines as orexin receptor antagonists
Grant 9,896,452 - Kamenecka , et al. February 20, 2
2018-02-20
6-membered Aza-heterocyclic Containing Delta-opioid Receptor Modulating Compounds, Methods Of Using And Making The Same
App 20170210725 - Speerschneider; Aimee Crombie ;   et al.
2017-07-27
Substituted Prolines / Piperidines As Orexin Receptor Antagonists
App 20170101410 - Kamenecka; Theodore M. ;   et al.
2017-04-13
Substituted prolines / piperidines as orexin receptor antagonists
Grant 9,499,517 - Kamenecka , et al. November 22, 2
2016-11-22
Substituted prolines/piperidines as orexin receptor antagonists
Grant 9,440,982 - Kamenecka , et al. September 13, 2
2016-09-13
Neuroactive Steroids, Compositions, And Uses Thereof
App 20160229887 - Martinez Botella; Gabriel ;   et al.
2016-08-11
Compounds, Methods And Formulations For The Oral Delivery Of A Glucagon-like Peptide (glp-1) Compound Or A Melanocortin-4 Receptor (mic4) Agonist Peptide
App 20140031287 - Herr; Robert Jason ;   et al.
2014-01-30
Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide
Grant 8,552,039 - Herr , et al. October 8, 2
2013-10-08
Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (Glp)-1 compound or a melanocortin-4 receptor (Mc4) agonist peptide
Grant 8,546,581 - Jungheim , et al. October 1, 2
2013-10-01
Pyridazinone derivatives useful as glucan synthase inhibitors
Grant 8,232,274 - Ting , et al. July 31, 2
2012-07-31
Bridged And Fused Heterocyclic Antidiabetic Compounds
App 20110312995 - Josien; Hubert B. ;   et al.
2011-12-22
Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide
App 20110190205 - JUNGHEIM; Louis Nickolaus ;   et al.
2011-08-04
Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptide
Grant 7,947,841 - Jungheim , et al. May 24, 2
2011-05-24
Compounds and Methods for Treating Dyslipidemia
App 20100204207 - Chen; Xinchao ;   et al.
2010-08-12
Compounds and methods for treating dislipidemia
Grant 7,749,992 - Cao , et al. July 6, 2
2010-07-06
Compounds, Methods And Formulations For The Oral Delivery Of A Glucagon-like Peptide (glp-1) Compound Or A Melanocortin-4 Receptor (mc4) Agonist Peptide
App 20100120876 - HERR; Robert Jason ;   et al.
2010-05-13
Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptide
Grant 7,662,771 - Herr , et al. February 16, 2
2010-02-16
Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide
App 20090239798 - Jungheim; Louis Nickolaus ;   et al.
2009-09-24
Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors
App 20090170861 - Ting; Pauline C. ;   et al.
2009-07-02
Bicyclic derivatives as PPAR modulators
Grant 7,544,707 - Connor , et al. June 9, 2
2009-06-09
Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide
App 20080214448 - Herr; Robert Jason ;   et al.
2008-09-04
Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide
App 20070293423 - Jungheim; Louis Nickolaus ;   et al.
2007-12-20
Compounds And Methods For Treating Dislipidemia
App 20070254869 - Cao; Guoqing ;   et al.
2007-11-01
Compounds and Method for Treating Dyslipidemia
App 20070244095 - Chen; Xinchao ;   et al.
2007-10-18
Bicyclic derivatives as ppar modulators
App 20070106081 - Conner; Scott Eugene ;   et al.
2007-05-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed